Strictly regulating an industry with high demand, like healthcare or vaping, often backfires. Instead of eliminating risk, it pushes consumers and providers into a "parallel" gray market that is less regulated, less coordinated, and ultimately more harmful. The intended consumer protection fails because the regulated system becomes too difficult to operate within, forcing activity outside the "kingdom walls."

MedVee's use of 800 fake doctor accounts and alleged spam generated huge sales. However, the resulting FDA warnings and lawsuits create immense regulatory risk, driving the company's long-term enterprise value near zero. This mirrors the playbook of illegal vape companies that prioritized rapid, unsustainable growth over compliance.

Established industries often operate like cartels with unwritten rules, such as avoiding aggressive marketing. New entrants gain a significant edge by deliberately violating these norms, forcing incumbents to react to a game they don't want to play. This creates differentiation beyond the core product or service.

Small, pre-approval psychedelic biotechs using paid YouTube promotions with exaggerated claims risk damaging the entire field's effort to build scientific legitimacy. This marketing tactic, typically seen with consumer products, undermines attempts to attract serious investors and pharma partners by creating hype that is harmful to the sector's credibility.

Marketing operates like venture capital, where a few massive hits, like American Express's "Member Since," generate most of the long-term value. However, it is held accountable for every penny of cost while only getting credit for a fraction of the long-term upside, creating a fundamental misalignment in how it's measured.

Counterintuitively, the tobacco industry thrives despite losing millions of customers. As casual smokers quit, the remaining base is more addicted and less price-sensitive. Companies exploit this by raising prices faster than sales volume declines, increasing profits from a shrinking market.

MedV's billion-dollar claim was based on a $1.8B revenue run-rate. This ignores crucial factors like thin margins from outsourcing, customer acquisition costs, and the long-term durability of a business model built on aggressive, legally questionable marketing tactics.

The founder of medical device company Alida notes that marketing her product for sexual wellness could boost short-term sales but would deter a potential acquisition by a traditional medical device company. This reveals a critical choice: founders must align today's marketing with their long-term exit strategy.

The industry glorifies aggressive revenue growth, but scaling an unprofitable model is a trap. If a business isn't profitable at $1 million, it will only amplify its losses at $5 million. Sustainable growth requires a strong financial foundation and a focus on the bottom line, not just the top.